Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Izawa

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Urologic Oncology|February 19, 2013
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinomaAndrew K Williams, Wassim Kassouf, Joseph Chin, et al.
BJU International|January 20, 2011
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohortRobert S Svatek, Shahrokh F Shariat, Giacomo Novara, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
The Journal of Urology|March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patientsDerya Tilki, Oliver Reich, Robert S Svatek, et al.
Urologic Oncology|January 14, 2014
Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaborationBassel G Bachir, Armen G Aprikian, Jonathan I Izawa, et al.
European Urology Oncology|April 2, 2023
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary CentersRonald Kool, Gautier Marcq, Rodney H Breau, et al.
BJU International|May 15, 2014
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective studyIlaria Lucca, Wassim Kassouf, Anil Kapoor, et al.
BJU International|November 20, 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
The Journal of Urology|December 21, 2010
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancerGuru Sonpavde, Myrna M Khan, Seth P Lerner, et al.
The Journal of Urology|November 28, 2009
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patientsDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Urologic Oncology|February 19, 2013
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinomaAndrew K Williams, Wassim Kassouf, Joseph Chin, et al.
BJU International|January 20, 2011
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohortRobert S Svatek, Shahrokh F Shariat, Giacomo Novara, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
The Journal of Urology|March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patientsDerya Tilki, Oliver Reich, Robert S Svatek, et al.
Urologic Oncology|January 14, 2014
Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaborationBassel G Bachir, Armen G Aprikian, Jonathan I Izawa, et al.
European Urology Oncology|April 2, 2023
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary CentersRonald Kool, Gautier Marcq, Rodney H Breau, et al.
BJU International|May 15, 2014
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective studyIlaria Lucca, Wassim Kassouf, Anil Kapoor, et al.
BJU International|November 20, 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
The Journal of Urology|December 21, 2010
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancerGuru Sonpavde, Myrna M Khan, Seth P Lerner, et al.
The Journal of Urology|November 28, 2009
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patientsDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
Pageof 12